Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Paula Herrero Abadia is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 2 Active
-
META-BEAT: Microbial enzyme targeting metabolism for cancer treatment
Julian Gomez, E. (Principal Investigator), Herrero Abadia, P. (Investigator), Martin Pinardi, L. (Others), Segui Moll, A. (Others) & Torrents Serra, E. (Others)
2/12/24 → 1/06/25
Project: Research Projects and Other Grants
-
NEXT-GENERATION OF IMMUNOTHERAPY AGENTS BASED ON ENGINEERED NON-TUBERCULOUS MYCOBACTERIA
Julian Gomez, E. (Principal Investigator), Luquin Fernandez, M. D. L. M. (Investigator), Rabanal Prados, R. M. (Investigator), Carbonell Segura, J. (Collaborator), Segui Moll, A. (Collaborator), Herrero Abadia, P. (Collaborator) & Campo Pérez, V. (Collaborator)
1/09/22 → 31/08/25
Project: Research Projects and Other Grants
-
Genomic analysis of Mycobacterium brumae sustains its nonpathogenic and immunogenic phenotype
Renau-Mínguez, C., Herrero-Abadía, P., Ruiz-Rodriguez, P., Sentandreu, V., Torrents, E., Chiner-Oms, Á., Torres-Puente, M., Comas, I., Julián, E. & Coscolla, M., 5 Jan 2023, In: Frontiers in Microbiology. 13, 19 p., 982679.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Genomic analysis ofMycobacterium brumaesustains its nonpathogenic and immunogenic phenotype
Renau-Mínguez, C., Herrero-Abadía, P., Sentandreu, V., Ruiz-Rodriguez, P., Torrents, E., Chiner-Oms, Á., Torres-Puente, M., Comas, I., Julián, E. & Coscolla, M., 2 Dec 2022, 26 p.Research output: Other contribution
Open Access -
Mycolicibacterium brumae is a safe and non-toxic immunomodulatory agent for cancer treatment
Bach-Griera, M., Campo-Pérez, V., Barbosa, S., Traserra, S., Guallar-Garrido, S., Moya-Andérico, L., Herrero-Abadía, P., Luquin, M., Rabanal, R. M., Torrents, E. & Julián, E., 25 Apr 2020, In: Vaccines. 8, 2, 198.Research output: Contribution to journal › Article › Research › peer-review
Open Access12 Citations (Scopus)
Thesis
-
Estudio in silico, in vitro y ex vivo de la actividad antitumoral de diferentes cepas de Mycobacterium Brumae y su papel en la activación y modulación del sistema inmune
Herrero Abadia, P. (Author), Julian Gomez, E. (Director), 2 Nov 2023Student thesis: Doctoral thesis